DLBCL

December 8, 2015May 13, 2016

New Non-Hodgkin Lymphoma Drug Combo Trial Launched by Amgen, Merck

News

Amgen and Merck are partnering to support a Phase 1b/3 clinical trial evaluating a cancer immunotherapy combination in patients with diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma (NHL). The ... Read more

November 3, 2015December 1, 2015

Molecular Key Found in Diffuse Large B-cell Lymphoma Development

News

A new study has identified the transcription factor FOXP1 as the main regulator in cancer cells’ ability to evade immune responses in patients with diffuse large B-cell lymphomas (DLBCL). The ... Read more

July 23, 2015July 23, 2015

Researchers Discover Link Between Specific Subset of Lymphomas and Metabolism

News

A new study led by researchers at the University of Texas Health Science Center at San Antonio has revealed a link between a type of lymphoma and a metabolism disruption. The ... Read more